Cargando…

Legislative, educational, policy and other interventions targeting physicians’ interaction with pharmaceutical companies: a systematic review

BACKGROUND: Pharmaceutical company representatives likely influence the prescribing habits and professional behaviour of physicians. OBJECTIVE: The objective of this study was to systematically review the effects of interventions targeting practising physicians’ interactions with pharmaceutical comp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkhaled, Lina, Kahale, Lara, Nass, Hala, Brax, Hneine, Fadlallah, Racha, Badr, Kamal, Akl, Elie A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091460/ https://www.ncbi.nlm.nih.gov/pubmed/24989618 http://dx.doi.org/10.1136/bmjopen-2014-004880

Ejemplares similares

Knowledge, beliefs and attitudes of physicians in low and middle-income countries regarding interacting with pharmaceutical companies: a systematic review
por: Lotfi, Tamara, et al.
Publicado: (2016)

Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review
por: Lotfi, Tamara, et al.
Publicado: (2015)

Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review
por: Fadlallah, Racha, et al.
Publicado: (2016)

Awareness and attitudes of the Lebanese population with regard to physician–pharmaceutical company interaction: a survey study
por: Ammous, Ahmad, et al.
Publicado: (2017)

Evidence synthesis to policy: development and implementation of an impact-oriented approach from the Eastern Mediterranean Region
por: El-Jardali, Fadi, et al.
Publicado: (2023)

Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation
por: Nissanholtz-Gannot, Rachel, et al.
Publicado: (2017)

Approaches to prioritising primary health research: a scoping review
por: Fadlallah, Racha, et al.
Publicado: (2022)

Using narratives to impact health policy-making: a systematic review
por: Fadlallah, Racha, et al.
Publicado: (2019)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Systematic reviews addressing identified health policy priorities in Eastern Mediterranean countries: a situational analysis
por: El-Jardali, Fadi, et al.
Publicado: (2014)

The SPARK Tool to prioritise questions for systematic reviews in health policy and systems research: development and initial validation
por: Akl, Elie A., et al.
Publicado: (2017)

Are Pharmaceutical Company Payments Incentivising Malpractice in Japanese Physicians?
por: Kobashi, Yurie, et al.
Publicado: (2019)

Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness
por: Fadlallah, Racha, et al.
Publicado: (2016)

Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
por: Mitchell, Aaron P, et al.
Publicado: (2022)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Correction to: Physician Payments from Pharmaceutical Companies Related to Cancer Drugs
Publicado: (2023)

Pharmacists’ views and reported practices in relation to a new generic drug substitution policy in Lebanon: a mixed methods study
por: El-Jardali, Fadi, et al.
Publicado: (2017)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

A review of national policies and strategies to improve quality of health care and patient safety: a case study from Lebanon and Jordan
por: El-Jardali, Fadi, et al.
Publicado: (2017)

Vitamin D supplementation in children with asthma: a systematic review and meta-analysis
por: Fares, Munes M, et al.
Publicado: (2015)

Prioritization approaches in the development of health practice guidelines: a systematic review
por: El-Harakeh, Amena, et al.
Publicado: (2019)

Serial Deaths of Young Trainee Physicians in Iran During COVID-19 Pandemic; Messages to Policy Makers
por: Gharebaghi, Reza, et al.
Publicado: (2022)

Willingness of Lebanese physicians in the United States to relocate to Lebanon
por: Akl, Elie A, et al.
Publicado: (2012)

Oil and gas companies invest in legislators that vote against the environment
por: Goldberg, Matthew H., et al.
Publicado: (2020)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

Off-label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authorities
por: Gupta, Sandeep Kumar, et al.
Publicado: (2014)

Doping Doctors: The Influence of the Marketing Departments of Pharmaceutical Companies on Physician and Researcher Behavior in Japan
por: Ichikawa, Iekuni, et al.
Publicado: (2016)

Community physicians’ attitudes towards meetings with representatives of pharmaceutical companies: a pilot study
por: Koplovitz, Amit, et al.
Publicado: (2023)

Overcoming Ethical Issues Surrounding the Relationships Between Physicians and Pharmaceutical Companies in Rural Hospitals
por: Ohta, Ryuichi, et al.
Publicado: (2023)

Reporting of conflicts of interest by authors of primary studies on health policy and systems research: a cross-sectional survey
por: Hakoum, Maram B, et al.
Publicado: (2020)

The implementation of prioritization exercises in the development and update of health practice guidelines: A scoping review
por: El-Harakeh, Amena, et al.
Publicado: (2020)

Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
por: Spurling, Geoffrey K., et al.
Publicado: (2010)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Effectiveness of Mechanisms and Models of Coordination between Organizations, Agencies and Bodies Providing or Financing Health Services in Humanitarian Crises: A Systematic Review
por: Akl, Elie A., et al.
Publicado: (2015)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Impact of a multifaceted intervention on physicians’ knowledge, attitudes and practices in relation to pharmaceutical incentivisation: protocol for a randomised control trial
por: Noor, Muhammad Naveed, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5l4s2mg6u1l2jko5aplj0gm4ju